Pragmatic, adaptive clinical trials: Is 2020 the dawning of a new age?
Given the high case fatality rate of SARS-CoV-2, for which 159 there is no cure and no vaccine, clinicians are forced to make decisions about how best to manage patients with limited high-quality evidence to guide treatment.Traditional randomized controlled trials provide strong experimental evidence, however, tend to be slow, inflexible, and have